טוען...
SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer
Background: Taxanes are frontline chemotherapeutic drugs for patients with triple-negative breast cancer (TNBC); however, chemoresistance reduces their effectiveness. We hypothesized that the molecular profiling of tumor samples before and after neoadjuvant chemotherapy (NAC) would help identify gen...
שמור ב:
| הוצא לאור ב: | Theranostics |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Ivyspring International Publisher
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7532662/ https://ncbi.nlm.nih.gov/pubmed/33042263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.45207 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|